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Abstract  
Introduction: Sebaceous Cyst carcinoma (SCC) is a rare aggressive skin cancer derived from the epithelium of 
sebaceous glands. Sebaceous cyst carcinoma accounts to <1% of cutaneous malignancy. Sebaceous cyst carcinomas 
are generally divided into those occurring in ocular (75%) or extraocular locations. SCC is very rare in axilla and 
confused with secondaries from breast carcinoma or lymphoma.  
Presentation of the case: Here we are presenting a case of 38 year old male, who presented with painless, progressive 
swelling on left axilla from one year. He was evaluated with ultrasound breast and axilla and a fine needle ultrasound 
from the swelling. The FNA of ulcerated lesion in the left axilla showed positive malignant epithelial cells. The tumour 
cells display oval hyperchromatic to vesicular nuclei with moderate nuclear pleomorphism, conspicuous nucleoli in 
places and scant cytoplasm. The tumour cells are strongly immunoreactive for CK7, EMA, and CD10, weakly and 
focally reactive for CK20, and non-reactive for vimentin.  
Conclusion: In conclusion, Sebaceous Cell Carcinoma is a rare and aggressive malignancy. The fumigating mass in 
the axilla may rarely be a sebaceous cyst carcinoma, may present with or without breast lump, prognosis is very poor 
therefore should be treated aggressively and adequately. 
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Introduction 
Sebaceous carcinoma or sebaceous cyst carcinoma (SCC) is a rare, highly malignant, and potentially 
lethal tumor of the skin, which is most commonly present in the eyelid. This neoplasm is an aggressive, 
malignant tumor arising from sebaceous glands of the skin and adnexa of different parts of body, such 
as the meibomian glands in the tarsus, the Zeis glands of the eyelashes, the caruncle, and the skin of 
the eyebrow. Many other carcinomas may show sebaceous differentiation; however, pure malignant 
sebaceous tumor is very rare tumor, with approximately 75% occurring in the periocular region [1]. 
This tumor is more frequent in Asian countries, comprising 33% of eyelid tumors and second behind 
basal cell carcinoma [2].  In USA, it is fourth cause of death after basal cell carcinoma, squamous cell 
carcinoma, and melanoma [3, 4]. SCC is very rare is axilla and confused with secondaries from breast 
carcinoma or lymphoma. 
Case Summary 
1. Case Presentation 
A 38 year old male presented with painless, progressive swelling in the left axilla from one year 
(Figure 1). It was not associated with swelling in the upper limb, any breast lump and swelling in 
other part of body. He does not have comorbidities like hypertension, diabetes mellitus, allergy to 
drugs and tuberculosis. There was no history of similar cancer in his family. He had history of cough 
and hemoptysis in past but no present symptoms was noticed. 
 
 
 
Figure 1 Patient examination revealed an ulceroproliferative growth on left axilla with fungating mass of 4x5cm 
diameter and mobile from chest wall. 
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On examination: he was average built with normal systemic examination findings. On left axilla he 
had a fungating mass of 4x5cm in largest diameter and mobile from chest wall (Figure 1). Few left 
axillary lymphnodes were enlarged and mobile. Breast and opposite axilla was clinically normal.   
He was evaluated with ultrasound of breast and axilla and a fine needle aspiration cytology 
under ultrasound guidance from the swelling. The Fine needle aspiration (FNA) smears from ulcerated 
lesion adjacent to left axilla show largely hemorrhage. Few cohesive clusters of atypical cells seen 
having high N:C ratio, hyperchromatic nuclei, occasional prominent nucleoli and mild to moderate 
amount of cytoplasm. The FNA ulcerated lesion left axilla showed positive malignant epithelial cells. 
He was diagnosed clinically as sebaceous cyst carcinoma and plan for wide local excision under 
general anesthesia. 
 
2. Surgical procedure and findings 
After adequate preoperative preparation, proper informed consent was taken for the surgery and 
possible complications. For SCC of left axilla, he underwent surgery under general anesthesia; the 
transverse skin crease incision around the axillary mass with 2 cm normal skin margin, the mass was 
excised. Through the same incision, clavipectoral fascia divided and entered into the axilla. Axillary 
vein was identified, dissected to antero-inferior surface of vein and cleared the axillary lymph node up 
to level 2 of axilla. Nerve to serratus anterior and nerve to latissimus dorsi were preserved. 
Intercosto-brachial nerve was sacrificed and haemostasis secured. 
Wide local excision of axillary mass with axillary lymph node dissection (ALND) was performed. 
The 4x4x8 cm ulceroproliferative mass in left axilla was excised, sup margin marked with suture and 
multiple enlarged node in level 1 and 2, was dissected. The specimen was send for histopathological 
examination. 
 
3. Histopathological examination 
From left axillary region tissue has been excised to see the histopathological changes in those areas 
(Figure 2, Figure 3a & 3b). Gross, measuring a size 5x4x3 cm and bearing a proliferative growth 
measuring 6x3cm. The growth was yellowish white and nodular with areas of necrosis. This growth 
was 2 cm from anterior and posterior margins, 0.4cm from superior margin, and 0.5cm from inferior 
margin. 20 lymph nodes were also received, largest measuring 2cm. Multiple pieces from growth and 
pieces from all the lymph nodes were embedded. 
The sections from the growth show a highly cellular dermal tumour disposed in lobules and 
nests composed of polygonal tumour cells, along with large areas of necrosis. The tumour cells display 
oval hyperchromatic to vesicular nuclei with moderate nuclear pleomorphism, conspicuous nucleoli in 
places and scant cytoplasm. The tumour cells towards the centre of lobules show sebaceous 
differentiation in the form of vesicular nuclei, prominent nucleoli and moderate to abundant finely 
vacuolated to foamy cytoplasm. Brisk mitosis is noted. The tumour is close (<2mm) to the superior 
margin. All other margins are free from tumour. The overlying epidermis is hyperplastic. All lymph 
nodes reveal reactive changes and are free of tumour (Figure 2). 
The tumour cells are strongly immunoreactive for CK7 (Figure 3a), EMA, and CD10, 
weakly and focally reactive for CK20 (Figure 3b), and non-reactive for vimentin. 
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Figure 2 Tumor growth show a highly cellular dermal tumor disposed in lobules and nests composed of 
polygonal tumour cells, along with large areas of necrosis. The tumour cells display oval hyperchromatic to 
vesicular nuclei with moderate nuclear pleomorphism, conspicuous nucleoli in places and scant cytoplasm. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3a Immunohistochemistry (IHC) photomicrograph showing the tumor cells are strongly immunoreactive 
for CK7 marker.  
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Figure 3b IHC photomicrograph showing the tumor cells are weakly and focally reactive for CK20 marker. 
Discussion 
Sebaceous carcinoma categorized into ocular and extra-ocular group. The ocular tumors commonly 
originate from the meibomian glands (51%) and glands of Zeiss (10%) on the eyelid [5]. The upper 
eyelid is involved 2 to 3 times more commonly than the lower eyelids [6, 7]. The extra-ocular lesions 
account for 20% of sebaceous carcinomas and are most commonly found in the head and neck region 
of elderly patients, including the scalp and face. Rarely, sebaceous carcinoma may be found on the 
trunk, genital region, extremities, and oral cavity [8-10]. Most commonly it occurs in parotid glands 
[11]. Ocular sebaceous carcinomas present as slowly enlarging, painless nodules of the eyelid margins 
or conjunctiva that may be clinically mistaken for benign inflammatory lesions, such as chalazions, 
blepharitis, and conjunctivitis. 
In our patient the sebaceous carcinoma presented as the fungating mass into the axilla 
therefore it was confused with the breast cancer with axillary metastasis and the investigation and 
management was directed accordingly. 
Pathological procedure is used for definitive diagnosis. The tumour frequently exhibits diverse clinical 
presentations and histologic patterns, often resulting delay in an accurate diagnosis [12]. Histology 
may SCC or may be uncertain [13]. In such cases initial evaluation for search of occult internal 
malignancy in breast, bone, pelvic lymph node, rectum etc. is required [14]. Therefore, mammography, 
IVU, Chest X-Ray, CT Abdomen, Complete blood picture, erythrocyte sedimentation rate (ESR), 
Renal and liver function tests, stool for occult blood and colonoscopy may be required [14]. 
Surgery is the main stay of treatment, local resection with 1cm margin [14. 15]. Other 
modality includes, Cryotherapy, chemotherapy with agents like 5-Fluorouracil [15], radiotherapy [15], 
isotretinoin 0.8mg/kg/day prevents cutaneous recurrence in the lesion [14]. Multimodal approach is 
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preferable. Radiation therapy should be reserved for patients unable or unwilling to undergo surgery 
[15]. 
The chief prognostic factor is the time of diagnosis of SCC. When diagnosis is made in the 
first initial six months the mortality rate is about 14% and rises to 38% after six month [16]. Factors 
associated with poor prognosis are vascular, lymphatic, orbital metastases, poor differentiation, 
multicentric origin, duration of symptoms more than six months, tumor diameter ˃10mm and a highly 
infiltrative pattern [17]. 
Conclusion 
The fungating mass in the axilla may rarely be a sebaceous cyst carcinoma, may present with or 
without breast lump or axillary lymphadenopathy, prognosis is very poor therefore should be treated 
aggressively and adequately. 
References 
1. Nelson BR, Hamlet KR, Gillard M, Railan D, Johnson TM. Sebaceous carcinoma. J Am 
AcadDermatol. 1995, 33(1):1-15 
2. Ni C, Searl SS, Kuo PK, Chu FR, Chong CS, Albert DM. Sebaceous cell carcinomas of the ocular 
adnexa. IntOphthalmolClin. 1982, 22(1):23-61 
3. Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: 
A clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol. 1982, 
13(2):113-122 
4. Kwitko ML, Boniuk M, Zimmerman LE. Eyelid tumors with reference to lesions confused with 
squamous cell carcinoma. I. Incidence and errors in diagnosis. Arch Ophthalmol. 1963, 
69:693-697 
5. Graham RM, McKee PH, McGibbon D. Sebaceous carcinoma. ClinExpDermatol. 1984, 
9(5):466-4714 
6. Wolfe JT, Yeatts RP, Wick MR, Campbell RJ, Waller RR. Sebaceous carcinoma of the eyelid. 
Errors in clinical and pathologic diagnosis. Am J SurgPathol. 1984, 8(8):597-606 
7. Callahan EF, Appert DL, Roenigk RK, Bartley GB. Sebaceous carcinoma of the eyelid: a review 
of 14 cases. Dermatol Surg. 2004, 30(8):1164-1168 
8. Carlson JW, McGlennen RC, Gomez R, Longbella C, Carter J, Carson LF. Sebaceous carcinoma 
of the vulva: a case report and review of the literature. GynecolOncol. 1996, 60(3):489-491 
9. Escalonilla P, Grilli R, Cañamero M, et al. Sebaceous carcinoma of the vulva. Am J 
Dermatopathol. 1999, 21(5):468-472 
10. Oppenheim AR. Sebaceous carcinoma of the penis. Arch Dermatol. 1981, 117(5):306-307 
11. Wick MR, Goellner JR, Wolfe JT, Su WP. Adnexal carcinomas of the skin. II. Extraocular 
sebaceous carcinomas. Cancer, 1985, 56(5):1163-1172 
12. Hammedi Faten, Trabelsi Amel, Belajouza Colanda, Beïzig Nadia, Gannouchi Nadia, Sriha 
Badreddine, Extra ocular sebaceous carcinoma of the thigh: A case report. N Am J Med Sci. 2010, 
2(1):48-50 
13. Tandon RK, Jasani J, Patel J, Patel A. Extra ocular sebaceous carcinoma of the sternum in biopsy: 
A case report. Indian Journal of Applied Basic Medical Sciences. 2012, 14B(19):119-123 
  
 
Ivy Union Publishing | http: //www.ivyunion.org            ISSN 2572-5742         January 18, 2017 | Volume 5, Issue 1 
 
Kumar A et al. American Journal of Cancer Case Reports 2017, 5:6-12 
6 
Page 7 of 7 
14. Ho C. K. Sebaceous Carcinoma. Hong Kong Dermatology & Venereology Bulletin. 2002, 
10(3):129-132 
15. Oh SH, Lee SS, Seo YJ. P75 Extraocular sebaceous carcinoma treated with wide excision and 
island flap, Melanoma Research. 2010, 20 :76-e77 
16. Panjwani PK, Tirumalae R, Crasta JA, Manjunath S, Rout P. Extraocular sebaceous carcinoma: a 
series of three cases with varied presentation. Dermatol Pract Conc. 2012, 2(1):7 
17. Daniel AO, Jon AR. Pathology of Sebaceous Carcinoma. medscape references. 2015 
 
 
